Maintenance of plasma IgM levels is critical for immune system function and homeostasis in humans and mice. However, the mechanisms that control homeostasis of the activated IgMsecreting B cells are unknown. After adoptive transfer into immune-deficient hosts, Blymphocytes expand poorly but fully reconstitute the pool of natural IgM-secreting cells and circulating IgM levels. By using sequential cell transfers and B cell populations from several mutant mice, we were able to identify novel mechanisms regulating the size of the IgMsecreting B cell pool. Contrary to previous mechanisms described regulating homeostasis, which involve competition for the same niche by cells having overlapping survival requirements, homeostasis of the innate IgM-secreting B cell pool is also achieved when B cells populations are able to monitor the number of activated B cells by detecting their secreted products. Notably, B cell populations are able to assess the density of activated B cells by sensing their secreted IgG. This process involves the FcγRIIB, a low-affinity IgG receptor that is expressed on B cells and acts as a negative regulator of B cell activation, and its intracellular effector the inositol phosphatase SHIP. As a result of the engagement of this inhibitory pathway the number of activated IgM-secreting B cells is kept under control. We hypothesize that malfunction of this quorum-sensing mechanism may lead to uncontrolled B cell activation and autoimmunity. 
Introduction
Maintenance of plasma IgM levels is critical for innate and adaptive immune system function and homeostasis in humans and mice. Decreased IgM levels result in diminished innate protection against bacterial invasion (1, 2) . In humans, splenectomy, a therapeutic measure following trauma, cancer or autoimmune diseases, results in increased susceptibility to bacterial infections (3); asplenic (Hox-11 -/-) or splenectomized mice also show diminished immune responses to bacterial infection (2) . Such reduction in the innate protection against bacterial invasion is related to decreases in both natural plasma IgM levels and the number of IgM-secreting cells (2) . In contrast, increased IgM titers are often associated with autoimmunity (4, 5) . For example, humans develop autoimmune disorders when they have primary immune deficiencies that are characterized by elevated natural IgM levels when Blymphocytes are unable to switch to IgG producing cells. These deficiencies could be due either to defective T-B cell cooperation, as is the case of CD40/CD40L deficiencies, or to an intrinsic inability of the B cells to perform class switch recombination (4, 5) . Similarly, increased IgM levels in mice are associated with several autoimmune disorders (6) . For example, mice with activation-induced cytidine deaminase (AID) defects that prevent class switch recombination develop hyper IgM-like syndromes that are associated with autoimmune diseases (7) . Thus, any failure to maintain the homeostasis of IgM-secreting B cells is deleterious, either by increasing susceptibility to infection or by inducing autoimmune disorders; however, the underlying mechanisms are unknown. In most cases, homeostatic regulation is achieved by competition of different cells for the same "survival niches" (8, 9 ).
However, it is unclear whether such mechanism would also apply to IgM homeostasis, as not only secreting B cell numbers should be maintained, but also the total amount of IgM they produce must also be regulated. It is also not clear, which mechanisms could limit lymphocyte 4 numbers during immune responses, in situations where resources are not limiting and physiological niches may be disrupted.
In here we report an experimental strategy allowing studying the mechanisms involved in this regulation. Indeed, in contrast to T lymphocytes that undergo considerable homeostatic expansion when transferred into immune-deficient (10) naïve B lymphocytes expand poorly but reach a stable equilibrium and fully reconstitute the pool of IgM-secreting B cells and circulating IgM levels (11) . The size and composition of this pool is tightly controlled as it remains stable for up to 6 months after transfer, independently of the number of injected naïve B cells (11) . Thus, in these host mice the number of Ig-secreting cells is kept under strict homeostatic regulation as observed in intact mice (8) . This model is therefore ideal to study the mechanisms of homeostasis of the number of IgM-secreting B cells, since only an adoptive transfer strategy allows the follow-up of different B cell populations (recognized by different allotypes) in the same mouse. Indeed, by using sequential transfers of B cell populations from several mutant mice, we identified feedback mechanisms regulating the size of the IgM-secreting B cell pool in a B-cell specific manner, i.e. excluding side effects induced by the mutations in other non-lymphoid cells. We found that contrary to the previous mechanisms described regulating homeostasis, which involve competition for the same niche by cells sharing overlapping survival signals (8, 9) , homeostasis of the innate IgM-secreting B cell pool is also achieved when B cell populations are able to monitor the number of activated B cells by detecting their secreted products. Notably, B cell populations are able to assess their density and limit the number of activated IgM-secreting B cells when they sense the levels of secreted IgG via FcγRIIB, a low affinity IgG receptor that is expressed on B cells and acts as a negative regulator of B cell activation (12) by a SH2-containing inositol-5-phosphatase 1 (SHIP1)-mediated pathway (12, 13) . These results reveal a new mechanism of homeostatic regulation, which recalls mechanisms found in procariots, which have been 5 collectively named as quorum sensing (14, 15) . Importantly, it finally explains the development of autoimmune conditions when IgG production is impaired, and the apparent paradox of the beneficial effects of IV Ig therapy in several autoimmune disorders (16 Consequently, the amount of IgM b that the second B cell population generated in the Ragdeficient hosts was significantly lower than the amount generated by the same cell population when transferred alone into naïve hosts ( Fig. 2b) . At the same time, total IgM levels were slightly greater in mice receiving both B cell populations ( Figure 2) , there was no inhibition of IgM production by the second B cell population (Fig. 3b) . We had observed that the level of feedback inhibition of the IgM production by the second B cell population was variable in different host mice injected with two WT populations. Considering that the feedback inhibition seems to be determined by the presence of IgG, we compared the IgM levels produced by the second B cell populations with the IgG levels present in individual mice from several different experiments. Notably, we found that the amount of IgM produced by the second B cell population inversely correlated with IgG levels in the host serum (Fig. 3c) .
To confirm the role of IgG in the feedback regulation of IgM production, we transferred LN cells into Rag2-deficient hosts that were either untreated (control) or injected with purified mouse IgG. The number of B cells with an activated phenotype and the IgM production were significantly reduced in the mice injected weekly with an IgG dose required to reach and maintain the physiological levels of serum IgG ( cell activation and IgM production are not inhibited.
In conclusion, our findings, clearly demonstrate that an active IgG-dependent suppressive mechanism can regulate IgM production. In the absence of IgG secretion by the first B cell population, IgM production by the second B cell population was not inhibited, and the amount of IgM produced by the second B cell population was inversely correlated with the IgG level in the host serum. More importantly, they indicate a presence of a yet nondescribed mechanism of homeostatic control. It has been proposed that homeostasis of Igsecreting cells is due to competition for a common niche of restricted size (8, 9 (12) . We found that the first (WT) B cell population did not suppress the second B cell population that lacked FcγRIIB (Fig. 4a, b) , but was able to suppress 50% of the IgM production by a population of WT B cells (Fig. 4b) . Inhibition of B cell activation may require FcγRIIB cross-linking, which can be achieved in the presence of either immune complexes or Ig aggregates (20) . Notably, as mentioned we found higher titers of self-reactive antibodies in the sera of cell transfer host mice than in donor mice (Fig. 1d ). (Fig. 4c, 4d ). Since these findings were obtained upon adoptive cell transfer into lymphocpenic hosts their validity could be questioned, as the new environment would not reflect that of an intact mouse.
Nevertheless, the size and composition of the IgM-secreting B cell pool remains stable for up to 6 months after transfer indicating that its homeostasis mimics the rules observed in intact mice. By using the strategy of sequential transfer of B cell populations from several mutant 13 mice, we were able to study the mechanisms regulating the size of a stable IgM-secreting B cell pool. Notably, our findings obtained using adoptive cell transfers, were fully supported by the observation that both intact non-manipulated FcγRIIB -/-and SHIP1 -/-mice had IgM serum levels that were significantly higher than those of control littermates (Fig. 4e) . Additionally, the cell transfer strategy demonstrated that these defects are B-cell specific and not induced by the lack of expression of the FcRIIB or SHIP1 on other non-lymphoid host cells. Taken together, these results show that there are feedback mechanisms that regulate the number of activated B cell and plasma IgM levels and that these mechanisms involve plasma IgG-and FcγRIIB-mediated, SHIP1-dependent negative signals (Supplementary Note 4 and Supplementary Fig. 4 ).
Discussion
The strategies to approach autoimmune disorders displaying elevated immunoglobulin Our findings also suggest an as-yet unsuspected physiological role for natural selfreactive antibodies. Specifically, it has never been clear why natural self-reactive Abs should be allowed to exist; but our observation of IgG-mediated feedback regulation of innate IgM in normal non-immunized mice suggests that natural self-reactive antibodies, which make up a significant fraction of the natural plasma Ig (43), by facilitating FcγRIIB aggregation provide a "warning signal" that reflects B cell density. Thus, natural self-reactive Abs might participate in activated B cell homeostasis under physiological steady-state conditions.
In conclusion, these results identify a new mechanism of homeostatic control. So far, in mammals, homeostatic control was believed to be due to competition of cellular populations for a common niche of restricted size, defined by the ensemble of cellular interactions and trophic factors required for cell survival (8, 44) . However, in situations where resources are not limiting, i.e. immune responses, excess of self-antigens or cytokines, it is not clear, which mechanisms could limit expanding lymphocyte numbers. Thus, the question: how lymphocyte populations "count" the number of their individuals and how do they "know" when to stop growing? We now show that in absence of competing cell populations, passively administered
IgG reduced activation and IgM production by subsequently introduced B cells. Thus, we
propose that control of lymphocyte numbers could also be achieved by the ability of lymphocytes to perceive the density of their own populations (44) . Such mechanism would be reminiscent of the primordial "quorum-sensing" systems used by some bacteria in which a bacterium senses the accumulation of bacterial signaling metabolites secreted (by the same or other cells), allowing the bacterium to sense the number of cells present in a population and adapt their growth accordingly (14, 15) . In summary, these "quorum-sensing" mechanisms allow bacteria to coordinate their gene expression according to the density of their population (14, 15) . Quorum sensing can play a critical role in lymphocyte homeostasis with the proviso that lymphocytes have the capacity to assess the number of molecules they interact with and can mount a standard response once a threshold number of molecules is detected. The situation described here seems to support this hypothesis. We found that homeostasis of the innate IgM-secreting B cell pool is achieved when total B cell populations are able to monitor the number of activated B cells by detecting products secreted by some of their members (Fig.   5a ). The ability of B cells to detect plasma IgG levels through such a "quorum-sensing" mechanism may be crucial to immune system homeostasis, providing a critical checkpoint mechanism to prevent excessive B cell activation and autoimmunity. Malfunction of this "quorum-sensing" mechanism may lead to uncontrolled B cell activation and autoimmune disease (Fig. 5b, c) . It is possible that similar quorum-sensing mechanisms may work to maintain the homeostasis of other lymphocyte populations (44) or control organ size during development. 
